Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triheptanoin for the Preventive Treatment of Migraine
NCT02784847Phase 1Unknown
- Sponsor
- University of Liège
- Start
- Jun 2016
- Primary completion
- Nov 2016
- Modality
- SLNs, Nanostructured Lipid Carriers, Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of triheptanoin in migraine, sponsored by University of Liège. Primary endpoint: Change in monthly migraine days at 3 months. Status: unknown.
02
Drugs
triheptanoin
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02784847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02784847.